ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 745943 Null 0.00359493104490023 -0.11884557
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.00359493104490023 0.31683458
NSC 762009 Copper(II) complex with quin as a ligand 0.00359493104490023 0.54127245
NSC 763232 Null 0.00359493104490023 0.35942309
NSC 87500 Solacongestidine 0.00359493104490023 0.22307637
NSC 156215 Streptovaricin complex, fraction b 0.00366577979610621 0.42722184
NSC 301457 Cycloalkannin 0.00366577979610621 0.74265424
NSC 331935 CHALCONE ANALOG 0.00366577979610621 0.49413785
NSC 625731 Null 0.00366577979610621 0.5111777
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.00366577979610621 0.69837542
Total:136  Current:26    [First] [Prev] [Next] [Last]